Painchek Ltd has released a press release.
Core strategic agreement with Dementia Support Australia
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from PainChek
- ePAT Clinical Study Published in Alzheimers Disease Journal
- nViso agrees perpetual global license, takes strategic stake
- ePAT Pain Assessment App Secures Regulatory Clearance
- New Study Validates Face Recognition App in Pain Detection
- Launch of IBM Case Study
Later from PainChek
- Placement to raise $3.75 million
- ePAT and PainChek continue to achieve commercial milestones
- 2nd peer-review confirms excellent performance of PainChek
- New Peer reviewed published study
- PainChek App Android version now in beta testing
Follow PainChek into a list and get an email when it puts out news.
Follow PainChek